Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Cue Health Inc. - Common Stock
(NQ:
HLTH
)
0.0434
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cue Health Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
12 Health Care Stocks Moving In Monday's After-Market Session
↗
July 17, 2023
Via
Benzinga
Cue Health Becomes First Company to Receive FDA De Novo Authorization COVID-19 Home Use Test
↗
June 07, 2023
Cue Health Inc (NASDAQ: HLTH) became the first company to receive De Novo authorization from the FDA for its Cue COVID-19 Molecular Test, designed for both home and
Via
Benzinga
Cue Health Achieves Groundbreaking Milestone with FDA: First Company to Receive De Novo Authorization for a COVID-19 Home Use Test
June 06, 2023
From
Cue Health
Via
Business Wire
Expert Ratings for Cue Health
↗
June 05, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
↗
June 05, 2023
Monday's session saw 41 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
June 06, 2023
On Tuesday, 69 stocks hit new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
June 02, 2023
Via
Benzinga
Recap: Cue Health Q1 Earnings
↗
May 10, 2023
Via
Benzinga
Earnings Preview: Cue Health
↗
May 09, 2023
Via
Benzinga
Cue Health Earnings Perspective: Return On Invested Capital
↗
March 16, 2023
Via
Benzinga
Cue Health's Earnings Outlook
↗
March 14, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 2, 2023
↗
June 02, 2023
Via
Benzinga
Cue Health to Present at the Goldman Sachs 44th Annual Global Healthcare Conference
May 31, 2023
From
Cue Health Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
May 18, 2023
Via
Benzinga
Cue Health Reports First Quarter 2023 Financial Results
May 10, 2023
From
Cue Health Inc.
Via
Business Wire
Cue Health Makes De Novo Submission to FDA for Full Clearance of its Cue® RSV Molecular Test
May 09, 2023
From
Cue Health
Via
Business Wire
Why Tredegar Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
May 08, 2023
Gainers Trevena, Inc. (NASDAQ: TRVN) shares surged 170% to $1.74 after the company announced the approval of OLINVYK in China.
Via
Benzinga
Cue Health Launches Pharmacy Offering to Empower Individuals to Manage Common Health and Wellness Needs from Home
May 08, 2023
From
Cue Health
Via
Business Wire
Cue Health to Announce First Quarter 2023 Financial Results
April 26, 2023
From
Cue Health Inc.
Via
Business Wire
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Cue Health Inc. and Encourages Investors with Losses to Contact the Firm
April 25, 2023
From
The Schall Law Firm
Via
Business Wire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Cue Health Inc. and Encourages Investors with Losses to Contact the Firm
April 25, 2023
From
The Schall Law Firm
Via
Business Wire
Cue Health Receives FDA Emergency Use Authorization for Molecular Mpox Test
March 20, 2023
From
Cue Health
Via
Business Wire
Cue Health Reports Fourth Quarter and Full-Year 2022 Financial Results
March 15, 2023
From
Cue Health Inc.
Via
Business Wire
Earnings Scheduled For March 15, 2023
↗
March 15, 2023
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million.
Via
Benzinga
Cue Health’s New Suite of At-Home Diagnostic Tests and Expansion of Cue Care Puts You in Control of Your Health
March 13, 2023
From
Cue Health
Via
Business Wire
Cue Health Collaborates with Pfizer to Provide People who Test Positive for COVID-19 with Actionable Health Information to Better Inform their Treatment Journey
March 02, 2023
From
Cue Health
Via
Business Wire
Cue Health to Announce Fourth Quarter and Full-Year 2022 Financial Results
March 01, 2023
From
Cue Health Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
February 17, 2023
Via
Benzinga
Cue Health to Participate at Upcoming Investor Conferences
February 02, 2023
From
Cue Health Inc.
Via
Business Wire
Why WestRock Company Are Trading Lower By 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
February 01, 2023
Gainers Versus Systems Inc. (NASDAQ: VS) surged 270% to $2.26 after the company announced it will partner with Resolve to bring generative AI and gamification to customer payments and credit...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today